Expert Ratings for DexCom
Portfolio Pulse from Benzinga Insights
In the last quarter, DexCom (NASDAQ:DXCM) received mostly bullish ratings from analysts, with 5 bullish, 3 somewhat bullish, and 1 indifferent. The company has an average 12-month price target of $147.0, with a high of $160.00 and a low of $130.00. The average price target has increased by 2.32% over the past month.
September 06, 2023 | 2:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
DexCom has received mostly bullish ratings from analysts in the last quarter, which could positively impact its stock price. The average 12-month price target has also increased over the past month.
Analyst ratings can significantly influence investor sentiment and, consequently, a company's stock price. The predominantly bullish ratings for DexCom suggest that analysts have a positive outlook on the company, which could encourage more investors to buy its stock. The increase in the average 12-month price target also indicates growing confidence in the company's future performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100